Classificação em ações
#2836
CG Oncology, Inc., a late-stage clinical biopharmaceutical company, develops... CG Oncology, Inc., a late-stage clinical biopharmaceutical company, develops and commercializes cretostimogene grenadenorepvec for patients with bladder cancer in the United States. The company’s product candidate is cretostimogene, an investigational oncolytic immunotherapy, which is in phase 2 clinical trials of cretostimogene in patients with high-risk NMIBC after BCG failure; a phase 3 clinical trials to evaluate the safety and efficacy of cretostimogene as monotherapy in the treatment of patients who have received adequate BCG therapy with high-risk BCG-unresponsive, CIS-containing NMIBC and BCG-unresponsive Ta, or T1 papillary tumors; phase 3 BOND-003 Cohort C trials as a single agent; phase 3 BOND-003 Cohort P as a single agent in patients with BCG-UR papillary-only NMIBC. It also develops cretostimogene monotherapy for intermediate-risk NMIBC following TURBT, which is in phase 3 PIVOT-006 clinical trials to assess the safety and efficacy of adjuvant cretostimogene; and cretostimogene monotherapy for high-risk NMIBC in phase 2 CORE-008 clinical trials to assess the safety and clinical outcomes of cretostimogene in treating patients with high-risk NMIBC, including BCG-exposed and BCG-naïve NMIBC. The company was formerly known as Cold Genesys, Inc. and changed its name to CG Oncology, Inc. in June 2020. CG Oncology, Inc. was founded in 2010 and is headquartered in Irvine, California.
Negociar CG Oncology Inc. (CGON)
Preço CGON com a capitalização de mercado de B
Capitalização de mercado de CG Oncology Inc.(CGON)
Valor de mercado: $6.96B
Em August 2026, CG Oncology Inc. tem uma capitalização de mercado de $6.96B. Isso faz com que CG Oncology Inc. seja a 2836th empresa mais valiosa do mundo em termos de capitalização de mercado, de acordo com os nossos dados. A capitalização de mercado, também chamada de market cap, é o valor total de mercado das ações em circulação de uma empresa de capital aberto e é amplamente utilizada para medir o valor de uma empresa.
Histórico de capitalização de mercado de CG Oncology Inc. de 2024 a 2026
CGON comparado com o topo de 5 mais populares stocks
| Preço para CGON |
|
Ativo B |
Capitalização de mercado de B |
Resultados |
|
|
|
|
$5.152T
|
+73,976.74%
|
|
|
|
|
$4.537T
|
+65,128.25%
|
|
|
|
|
$4.169T
|
+59,831.04%
|
|
|
|
|
$3.642T
|
+52,265.67%
|
|
|
|
|
$2.805T
|
+40,222.92%
|
